Post by Guillaume Wendt, PhD

Europe—and Germany in particular—has a unique opportunity to accelerate clinical research through the responsible use of health data. Health data can act as a catalyser bridge—connecting research, innovation and care—to speed up (clinical) drug development and ultimately improve patient outcomes. Recently, we had the opportunity to meet in Berlin with key stakeholders across the ecosystem to openly discuss how we can make this happen—together. To fully unlock this potential, we need simple, harmonized procedures, streamlined access, and—just as importantly—all stakeholders aligning and looking in the same direction: regulators, healthcare providers, researchers (academic or private), patients and more. With high‑quality data, advanced analytics, and privacy‑preserving, federated approaches, initiatives like EHDS can be translated into real impact—faster, better, and more relevant evidence for improved patient care. #HealthData #ClinicalResearch #PatientCare #RealWorldEvidence #EHDS #Germany #Europe #HealthcareInnovation #EvidenceGeneration Dominik Humm, Kurt Höller, Nick Schneider, Dominik Roters, Dr. Thomas Pauls, Dr. Konrad Körner, Janina Beilner Prof. Dr., Marina Leonie Moskvina